BILL · 2001–02 SESSION
SB 6150: Human subjects research
Mandating disclosure of beneficial interests in human subject research.
Summary
- A licensed health care provider or a health care facility is prohibited from administering or providing a drug or other product to a human research subject without disclosing any ? beneficial interest," as defined in current law, in the drug, product, or entity promoting the drug or product.
From the Senate Bill Report (SB 6150), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedMar 21, 2001
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Pat Thibaudeau (D-43)
- Introduced
- March 21, 2001 in the Senate
- Last action
- January 14, 2002
AN ACT Relating to disclosure of beneficial interests in drugs or products administered or provided to human subjects participating in human subjects research;
Sponsors
Prime sponsor: Pat Thibaudeau (D-43)
3 co-sponsors (2 Democrats, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health & Long-Term Care.
SB 6150 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6150 (2025–26) Fairfax bridge closure/tax
- SB 6150 (2023–24) Comprehensive plan revisions
- SB 6150 (2019–20) GMA actions effective date
- SB 6150 (2017–18) Opioid use disorder
- SB 6150 (2015–16) Water pollution loans/term
- SB 6150 (2013–14) Medal of Honor license plate
- SB 6150 (2011–12) Facial recognition matching
- SB 6150 (2009–10) Health tech assessment prog